Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FNJTE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,008
Award facts
- Contract value 100% obligated
- $10,007.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,007.93 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Dupixent 300 mg/2 mL pens (2 mL units). This is a firm fixed price, non-competitive delivery order with an ultimate completion date of July 31, 2025, and represents a pediatric or adult atopic dermatitis and eosinophilic condition therapeutic supply for federal medical needs. The contract is classified as a child award under a larger indefinite delivery vehicle, with performance conducted at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania.
This delivery order is executed under AmerisourceBergen's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains, supporting the DLA Medical Supply Chain's mission to provide critical healthcare commodities to the Department of Defense and related federal medical entities.
Quick answers
Who was awarded contract SPE2DB25FNJTE?
SPE2DB25FNJTE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FNJTE worth?
The government has obligated $10,008 on SPE2DB25FNJTE.
Is contract SPE2DB25FNJTE an order under another contract?
Yes. SPE2DB25FNJTE is a delivery order under SPE2DB20D1004, an indefinite delivery contract.
Was contract SPE2DB25FNJTE competed?
The extent of competition for SPE2DB25FNJTE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award